Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

June 9 2023 - AstraZeneca teams up with startup Quell in type 1 diabetes, IBD cell therapy pact

AstraZeneca teams up with startup Quell in type 1 diabetes, IBD cell therapy pact
Activist shareholders blast Merck's IRA lawsuit, urge company to reconsider
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings

Abbott Labs says regulators request more info on controlled-release painkiller Vicodin

Yahoo/AP

Tuesday, October 21, 2008 - 9:32am

tags:

Novartis Moves to the Next Stage

Businessweek

Tuesday, October 21, 2008 - 9:31am

tags:

Amgen up 15 pct year-to-date; hope for blockbuster osteoporosis drug defends against declines

Yahoo/AP

Tuesday, October 21, 2008 - 9:30am

tags:

Novartis & Biotechs: ‘I Don’t Think We’ve Seen the Trough’

WSJ Online

Tuesday, October 21, 2008 - 9:29am

tags:

Foolish Forecast: Will Pfizer Flounder Through Another Quarter?

Motley Fool

Tuesday, October 21, 2008 - 9:28am

tags:

Takeda Rises as Buyback Plan Outweighs Drug Delays

Bloomberg

Tuesday, October 21, 2008 - 9:27am

tags:

Novartis CEO Seeks Biotechs Needing Funds, Investors

Bloomberg

Tuesday, October 21, 2008 - 9:26am

tags:

Actavis plays down sale rumours

FT.com

Monday, October 20, 2008 - 11:33am

tags:

Biogen works to stave off proxy fights

Fierce Pharma

Monday, October 20, 2008 - 11:32am

tags:

Drug stocks move forward with broader market

Marketwatch

Monday, October 20, 2008 - 11:30am

tags:

[video]TheStreet.com BioTalk: Big-Cap Breakdown

The Street.com

Monday, October 20, 2008 - 11:22am

tags:

Don't Get Burned by the Next Cell Genesys

The Street.com

Monday, October 20, 2008 - 10:45am

tags:

FDA delays approval of Forest's antidepressant milnacipran

Marketwatch

Monday, October 20, 2008 - 10:38am

tags:

Gilead Offers Opportunities

Yahoo/Zacks.com

Monday, October 20, 2008 - 10:37am

tags:

Ten Highest Yielding Pharma Stocks

Seeking Alpha

Monday, October 20, 2008 - 10:36am

tags:

The Vytorin Limbo: Going Lower All The Time

Pharmalot

Monday, October 20, 2008 - 9:51am

tags:

Pfizer, UCB, U.K. government team up for R&D project

Marketwatch

Monday, October 20, 2008 - 9:49am

tags:

Novartis A Picture Of Health (For Now)

Forbes

Monday, October 20, 2008 - 9:48am

tags:

Novartis Earnings Rise 32%

The Street.com

Monday, October 20, 2008 - 9:48am

tags:

Novartis Changes Division Heads, Plans U.S. Job Cuts

Bloomberg

Monday, October 20, 2008 - 9:42am

tags:

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Klick Health launches new healthcare venture studio

Medtech earnings reports: insights from major players' Q4 results

Key compliance issues for medtech firms transitioning to data-enabled solutions

Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

Long Covid Shows A Card?

In the Pipeline

Helping Patients Ease Medication-Affordability Anxiety

Drug Channels

Microbiome Uncertainties

In the Pipeline

Drug Pricing Restrictions: Oh Joy

In the Pipeline

Just Stick 'Em Together

In the Pipeline

Pharmacist Salaries and Employment in 2022: The Good Times Roll for Retail Pharmacists

Drug Channels

thINc’s Specialty Networks and Patient Support Services Summit

Drug Channels

The Drug Discount Ecosystem’s “Mission Critical”

Drug Channels

Fakin' It the Modern Way

In the Pipeline